Transcriptomic analysis of the BRCA-Basal subtype, which includes most TNBC cases in The Cancer Genome Atlas (TCGA) dataset, revealed that RANKL expression correlates with increased CD4+ T-cell infiltration and lower tumor purity, indicating immune cell origin and higher metastatic risk. This evidence concerns the gene CD4 and neoplasm.